![]() |
市場調查報告書
商品編碼
1828171
2025年全球血壓監測市場報告Sphygmomanometer Global Market Report 2025 |
近年來,血壓監測儀市場規模強勁成長,從2024年的29.8億美元成長到2025年的32億美元,複合年成長率為7.5%。預測期內的成長可歸因於建設產業的成長、農業領域的需求、多功能性和覆蓋範圍、基礎設施計劃、物料輸送效率的提高以及租賃市場的需求。
預計未來幾年血壓監測儀市場將快速成長,到2029年將達到47.7億美元,複合年成長率為10.5%。預測期內的成長歸因於可再生能源計劃、都市化和垂直建設、精密農業實踐、對環境永續性的日益重視、安全法規的合規性以及全球經濟的復甦。預測期內的主要趨勢包括產品創新、緊湊靈活的設計、電動和混合模式、遠端資訊處理和物聯網的整合以及高強度材料的使用。
血壓計是一種用於測量血壓(尤其是動脈壓)的儀器。它由一個用於限制血流的充氣袖帶和一個用於測量壓力的儀表組成。
血壓監測儀的主要類型包括電子血壓計、氣表式血壓計和水銀血壓計。電子血壓計是用來測量血壓的醫療設備。它們可用於臨床環境,也適合在家中自我監測。這些電子血壓計有多種配置,包括可攜式、桌上型、落地式和壁掛式。它們還可以是電動、手動、自動或半自動的。這些設備通常用於各種醫療保健環境,包括醫院、門診手術中心、診所、居家醫療和其他最終用戶環境。
2025年美國關稅大幅上調及其引發的貿易摩擦,對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品的影響尤其顯著。由於醫院和診所抵制價格上漲,製造商面臨利潤壓力。監管挑戰使情況更加複雜,因為由於關稅而更換供應商通常需要重新認證醫療設備,導致市場進入延遲。為此,企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。
本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分,該系列提供了血壓監測儀市場統計數據,包括全球市場規模、區域佔有率、血壓監測儀市場佔有率競爭對手、詳細的血壓監測儀細分市場、市場趨勢和商機,以及在血壓監測儀行業取得成功所需的數據。本血壓監測儀市場研究報告提供了全面的展望,並詳細分析了該行業的現狀和未來趨勢。
我們預測未來五年該市場將成長10.5%,較先前預測略有下降0.2%。下降的主要原因是美國與其他國家之間關稅的影響。這種影響可能會對美國產生直接影響,因為它可能會減少來自中國和美國等主要地區的精密壓力感測器和橡膠管的供應,這可能會推高手動和電子血壓計的價格。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響,這種影響也可能更為廣泛。
血壓監測儀市場的預期成長是由糖尿病、高血壓和缺血性心臟疾病等慢性疾病日益流行的所推動的。慢性病的特徵是病程長,需要持續的管理和醫療照護。血壓監測儀在這些疾病的管理中發揮關鍵作用,它有助於診斷、監測心血管健康和識別高血壓的次要原因。例如,根據2022年12月《美國心臟病學會雜誌》(JACC)的數據,2021年僅缺血性心臟疾病就導致944萬人死於心血管疾病,而高血壓性心臟疾病和肺動脈高血壓分別導致141萬人和23,300人死亡。慢性病盛行率的上升凸顯了血壓監測儀在醫療保健中的重要性,並正在推動市場成長。
預計門診手術中心數量的增加將顯著促進血壓監測儀市場的成長。門診手術中心 (ASC) 的目標是在無需住院的情況下進行手術,並在整個手術過程中高度依賴血壓計(血壓袖帶)監測患者的生命徵象。根據 VMG Health 於 2023 年 9 月發布的最新數據,獲得聯邦醫療保險 (Medicare) 認證的門診手術中心總數將從 2021 年的 1,752 家增加 2.9%,到 2022 年將增至 1,804 家。門診手術中心數量的增加反映了醫療保健環境的不斷擴展,並推動了這些機構對血壓監測儀的需求。
血壓監測儀市場的主要企業正致力於開發自動血壓監測儀等創新產品,以提高測量精度、改善使用者體驗並實現持續血壓監測,從而改善高血壓和心血管健康管理。自動血壓監測儀是一種使用充氣袖帶和示波法技術測量血壓的電子設備。它們可以精確測量收縮壓、舒張壓以及脈搏率,方便在家中自我監測。例如,2022 年 2 月,專注於身體組成技術的韓國公司 InBody 推出了 BP 170。這款家用自動血壓監測儀採用示波法技術,可精確測量收縮壓、舒張壓和脈搏率。它具有易於使用的一鍵式袖帶、大尺寸易讀顯示器以及儲存多名用戶測量數據的功能,非常適合家庭健康監測。此外,該設備已通過臨床檢驗,可確保可靠的結果並有效支持使用者的心血管健康管理。
為了鞏固競爭地位,血壓監測儀市場的主要企業正在積極開發創新型血壓監測儀,尤其是家用自動血壓監測儀。這些設備讓使用者能夠在家中舒適地監測血壓。 2022年2月,韓國健康與保健技術供應商Inbody推出了InBody BP 170家用設備。這款經臨床檢驗的自動血壓監測儀可以測量收縮壓、舒張壓和脈搏率。本設備採用示波法技術,可準確監測脈搏率和血壓的每日波動。 BP 170可以透過藍牙連接到InBody應用程式,方便使用者追蹤血壓測量值。
2022年11月,日本醫療科技領導者歐姆龍健康株式會社與CardioSignal達成合作,共同推動心血管疾病的早期發現,並促進大規模遠端患者監護。此次合作旨在透過將CardioSignal的創新遠端心臟監測技術整合到歐姆龍健康現有的產品線中,增強歐姆龍健康為患者和醫療保健專業人員提供即時健康洞察的能力。 CardioSignal是一家美國公司,以其能夠早期發現心血管疾病的行動應用程式而聞名。
血壓監測儀市場的主要企業包括 A&D Company Ltd.、American Diagnostic Corporation、Omron Healthcare Inc.、Microlife Corporation、Acoma Medical Industry Co.Ltd.、Beurer GmbH、通用電氣公司、Amico Group of Companies、CIGA Healthcare Ltd.、HEINE Optotechnik GmbH、通用電氣公司、Amico Group of Companies、Gmb Healthcare Ltd.、HEINE Optotechnik GmbH and Co.K.Rudoonn. NV、Paul Hartmann AG、3B Scientific、Hill-Rom Services Inc.、Sklar Surgical Instruments、Spengler、Holtex Ltd.、Timesco Healthcare Ltd.、Bremed Ltd.、iHealth Labs Inc.、Contec Medical Systems Co.Ltd.、Halma plc 和 SunTech Medical Inc.
2024年,北美是血壓監測儀市場最大的地區。預計亞太地區將成為預測期內全球血壓監測儀市場成長最快的地區。血壓監測儀市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。
血壓監測儀市場報告涉及的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利和西班牙。
血壓監測儀市場涵蓋數位、攜帶式和混合式血壓監測儀的銷售。該市場的價值指的是“出廠價”,即商品製造商或生產商銷售給其他營業單位(包括下游製造商、批發商、經銷商和零售商)或直接銷售給最終客戶的價值。該市場中的商品價值還包括商品製造商銷售的任何相關服務。
A sphygmomanometer is a device designed for measuring blood pressure, specifically the pressure in arteries. It comprises an inflatable cuff, which is used to restrict blood flow, and a gauge to measure the pressure.
The primary types of sphygmomanometers include electronic sphygmomanometers, aneroid sphygmomanometers, and mercury sphygmomanometers. An electronic sphygmomanometer is a medical device utilized for measuring blood pressure. It finds applications in clinical settings and is also suitable for self-monitoring of blood pressure at home. These electronic sphygmomanometers come in various configurations, including portable, desk-mounted, floor-standing, and wall-mounted options. They operate using electricity and may be manual, automatic, or semi-automatic. These devices are commonly employed in diverse healthcare settings such as hospitals, ambulatory surgical centers, clinics, home healthcare, and other end-user environments.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The sphygmomanometer market research report is one of a series of new reports from The Business Research Company that provides sphygmomanometer market statistics, including sphygmomanometer industry global market size, regional shares, competitors with a sphygmomanometer market share, detailed sphygmomanometer market segments, market trends and opportunities, and any further data you may need to thrive in the sphygmomanometer industry. This sphygmomanometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sphygmomanometer market size has grown strongly in recent years. It will grow from $2.98 billion in 2024 to $3.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.5%. The growth in the historic period can be attributed to construction industry growth, agricultural sector demand, versatility and reach, infrastructure projects, efficiency in material handling, demand from rental market.
The sphygmomanometer market size is expected to see rapid growth in the next few years. It will grow to $4.77 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to renewable energy projects, urbanization and vertical construction, precision agriculture practices, focus on environmental sustainability, safety regulations compliance, global economic recovery. Major trends in the forecast period include product innovation, compact and maneuverable designs, electric and hybrid models, integration of telematics and iot, use of high-strength materials.
The forecast of 10.5% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through reduced availability of precision pressure sensors and rubber tubing, sourced from key regions such as China and Malaysia, which could lead to inflated prices for both manual and digital blood pressure monitors.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated growth in the sphygmomanometer market is driven by the increasing prevalence of chronic illnesses such as diabetes, hypertension, and ischemic heart disease. Chronic illnesses, characterized by their long-lasting nature, necessitate ongoing management and medical care. Sphygmomanometers play a crucial role in the management of these conditions, aiding in diagnosis, monitoring cardiovascular health, and identifying secondary causes of hypertension. For example, data from the Journal of the American College of Cardiology (JACC) in December 2022 revealed that ischemic heart disease alone accounted for 9.44 million cardiovascular deaths in 2021, with hypertensive heart disease and pulmonary arterial hypertension contributing to 1.41 million and 23,300 deaths, respectively. The rising prevalence of chronic illnesses underscores the importance of sphygmomanometers in healthcare, driving market growth.
The increasing number of ambulatory surgery centers is expected to contribute significantly to the growth of the sphygmomanometer market. Ambulatory Surgery Centers (ASCs), dedicated to performing surgical procedures without overnight hospital stays, heavily rely on sphygmomanometers (blood pressure cuffs) to monitor patients' vital signs throughout the surgical process. Recent data from VMG Health in September 2023 indicates a 2.9% increase in the total number of Medicare-certified ambulatory surgery centers, from 1752 in 2021 to 1804 in 2022. This growth in ambulatory surgery centers reflects an expanding healthcare landscape, driving the demand for sphygmomanometers in these facilities.
Major companies in the sphygmomanometer market are focusing on developing innovative products like automatic blood pressure monitors to enhance accuracy, improve user experience, and enable continuous monitoring of blood pressure for better management of hypertension and cardiovascular health. Automatic blood pressure monitors are electronic devices that measure blood pressure using an inflatable cuff and oscillometric technology, providing precise readings of systolic and diastolic pressures along with pulse rate for convenient self-monitoring at home. For example, in February 2022, InBody, a South Korea-based company specializing in body composition technology, launched the BP 170. This automatic blood pressure monitor is designed for home use and employs oscillometric technology to deliver accurate measurements of systolic and diastolic blood pressure as well as pulse rate. It features a user-friendly one-touch cuff for easy application, a large display for better visibility, and the ability to store readings for multiple users, making it suitable for family health monitoring. Furthermore, the device is clinically validated, ensuring reliable results that help users effectively manage their cardiovascular health.
Major companies in the sphygmomanometer market are actively engaged in developing innovative monitors, particularly at-home automatic blood pressure monitors, to gain a competitive edge. These devices allow individuals to measure blood pressure conveniently from the comfort of their homes. In February 2022, Inbody, a South Korea-based provider of health and wellness technology, introduced the InBody BP 170 at-home device. This clinically validated automatic blood pressure monitor enables users to measure systolic and diastolic blood pressure as well as pulse rate. The device utilizes an oscillometric technique to precisely monitor daily variations in pulse rate and blood pressure. The BP 170 can be connected to the InBody app via Bluetooth, enabling users to track blood pressure readings over time.
In November 2022, OMRON Healthcare, Co., Ltd., a Japan-based leader in healthcare technology, partnered with CardioSignal to advance early detection of cardiovascular disease and facilitate remote patient monitoring at scale. This collaboration aims to integrate CardioSignal's innovative remote cardiac monitoring technology with OMRON Healthcare's existing product lineup, enhancing the ability to deliver real-time health insights for both patients and healthcare professionals. CardioSignal is a US-based company recognized for its mobile applications that enable the early detection of cardiovascular issues.
Major companies operating in the sphygmomanometer market include A&D Company Ltd., American Diagnostic Corporation, Omron Healthcare Inc., Microlife Corporation, Acoma Medical Industry Co. Ltd., Beurer GmbH, General Electric Company, Amico Group of Companies, CIGA Healthcare Ltd., HEINE Optotechnik GmbH and Co. KG, Rossmax International Ltd., Rudolf Riester GmbH, Welch Allyn Inc., Koninklijke Philips N.V., Paul Hartmann AG, 3B Scientific, Hill-Rom Services Inc., Sklar Surgical Instruments, Spengler, Holtex Ltd., Timesco Healthcare Ltd., Bremed Ltd., iHealth Labs Inc., Contec Medical Systems Co. Ltd., Halma plc, SunTech Medical Inc.
North America was the largest region in the sphygmomanometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global sphygmomanometer market during the forecast period. The regions covered in the sphygmomanometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the sphygmomanometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sphygmomanometer market consists of the sale of digital sphygmomanometers, portable sphygmomanometers, and hybrid sphygmomanometers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sphygmomanometer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on sphygmomanometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sphygmomanometer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sphygmomanometer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.